Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197


Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M, Ferrini S, Chouaib S, Vazquez A, Charpentier B, Camussi G, Azzarone B, Eid P.

J Natl Cancer Inst. 2011 Dec 21;103(24):1884-98. doi: 10.1093/jnci/djr451. Epub 2011 Oct 31.


BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.

Wang L, Park P, La Marca F, Than KD, Lin CY.

J Cancer Res Clin Oncol. 2015 Jun;141(6):1013-24. doi: 10.1007/s00432-014-1883-0. Epub 2014 Nov 28.


Human renal cancer stem cells.

Bussolati B, Dekel B, Azzarone B, Camussi G.

Cancer Lett. 2013 Sep 10;338(1):141-6. doi: 10.1016/j.canlet.2012.05.007. Epub 2012 May 12. Review.


Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.

Prud'homme GJ, Glinka Y, Toulina A, Ace O, Subramaniam V, Jothy S.

PLoS One. 2010 Nov 3;5(11):e13831. doi: 10.1371/journal.pone.0013831.


Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.

Lin JJ, Huang CS, Yu J, Liao GS, Lien HC, Hung JT, Lin RJ, Chou FP, Yeh KT, Yu AL.

Breast Cancer Res. 2014 Mar 26;16(2):R29. doi: 10.1186/bcr3631.


Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.

Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A.

J Natl Cancer Inst. 2016 Sep 15;109(1). pii: djw189. doi: 10.1093/jnci/djw189. Print 2017 Jan.


Sphere formation assay is not an effective method for cancer stem cell derivation and characterization from the Caco-2 colorectal cell line.

Wu H, Zhang H, Hu Y, Xia Q, Liu C, Li Y, Yu B, Gu T, Zhang X, Yu X, Kong W.

Curr Stem Cell Res Ther. 2014 Mar;9(2):82-8.


Identification of a tumor-initiating stem cell population in human renal carcinomas.

Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G.

FASEB J. 2008 Oct;22(10):3696-705. doi: 10.1096/fj.08-102590. Epub 2008 Jul 9.


Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.

Zhong Y, Guan K, Guo S, Zhou C, Wang D, Ma W, Zhang Y, Li C, Zhang S.

Cancer Lett. 2010 Dec 28;299(2):150-60. doi: 10.1016/j.canlet.2010.08.013. Epub 2010 Sep 16.


Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.

Zhang G, Ma L, Xie YK, Miao XB, Jin C.

Mol Med Rep. 2012 Sep;6(3):519-24. doi: 10.3892/mmr.2012.939. Epub 2012 Jun 8.


Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.

Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA.

Stem Cells. 2012 Nov;30(11):2366-77. doi: 10.1002/stem.1219.


Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ.

Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15.


Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.

Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA.

Br J Cancer. 2010 Apr 13;102(8):1265-75. doi: 10.1038/sj.bjc.6605610. Epub 2010 Mar 23.


The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.

Li D, Zhang T, Gu W, Li P, Cheng X, Tong T, Wang W.

Oncol Rep. 2015 May;33(5):2291-8. doi: 10.3892/or.2015.3842. Epub 2015 Mar 9.


Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.

Yang B, Lu Y, Zhang A, Zhou A, Zhang L, Zhang L, Gao L, Zang Y, Tang X, Sun L.

PLoS One. 2015 Jun 25;10(6):e0129138. doi: 10.1371/journal.pone.0129138. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134201.


Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.

Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.

Int J Cancer. 2012 Jan 1;130(1):29-39. doi: 10.1002/ijc.25967. Epub 2011 Apr 8.


High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.

Farnie G, Sotgia F, Lisanti MP.

Oncotarget. 2015 Oct 13;6(31):30472-86. doi: 10.18632/oncotarget.5401.


miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.

Sheng W, Chen Y, Gong Y, Dong T, Zhang B, Gao W.

Oncol Rep. 2016 Dec;36(6):3387-3396. doi: 10.3892/or.2016.5203. Epub 2016 Oct 25.


Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.

Ueda K, Ogasawara S, Akiba J, Nakayama M, Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K, Yano H.

PLoS One. 2013 Oct 8;8(10):e75463. doi: 10.1371/journal.pone.0075463. eCollection 2013.


Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.

Larzabal L, El-Nikhely N, Redrado M, Seeger W, Savai R, Calvo A.

PLoS One. 2013 Nov 20;8(11):e79798. doi: 10.1371/journal.pone.0079798. eCollection 2013.

Supplemental Content

Support Center